SECTOR : Biotech
ENTRY DATE : 2021
BUSINESS : Venture Capital
WEB : www.corteriapharma.com/
Corteria Pharmaceuticals
Advancing therapies for cardiovascular disease
Corteria Pharmaceuticals is a French biotechnology company specialized in the development of interceptive therapies for heart failure sub-populations.
PRESS RELEASE(S) :
09/12/2021 • Corteria Pharmaceuticals Announces Closing of €12M Seed Financing to Advance Portfolio Assets